CLOUDR GROUP LTD. Asset Resilience Ratio
CLOUDR GROUP LTD. asset resilience ratio. CLOUDR GROUP LTD. (H3L) has an Asset Resilience Ratio of 3.25% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CLOUDR GROUP LTD. defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of CLOUDR GROUP LTD. (2021–2024)
Asset resilience ratio of CLOUDR GROUP LTD. from 2021 to 2024. This chart shows how CLOUDR GROUP LTD.'s Asset Resilience Ratio has changed over time. Read CLOUDR GROUP LTD. balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down CLOUDR GROUP LTD.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see H3L total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €69.96 Million | 3.25% |
| Total Liquid Assets | €69.96 Million | 3.25% |
Asset Resilience Insights
- Limited Liquidity: CLOUDR GROUP LTD. maintains only 3.25% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CLOUDR GROUP LTD. Industry Peers by Asset Resilience Ratio
Compare CLOUDR GROUP LTD.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.04% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
ShareHope Medicine Co Ltd
TWO:8403 |
Medical Distribution | 3.61% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
CLOUDR GROUP LTD. Asset Resilience Ratio by Year (2021–2024)
CLOUDR GROUP LTD. asset resilience ratio by year from 2021 to 2024. The table below shows the annual Asset Resilience Ratio data for CLOUDR GROUP LTD..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.99% | €227.35 Million ≈ $265.80 Million |
€2.84 Billion ≈ $3.33 Billion |
-3.95pp |
| 2023-12-31 | 11.94% | €351.72 Million ≈ $411.20 Million |
€2.95 Billion ≈ $3.44 Billion |
-4.76pp |
| 2022-12-31 | 16.71% | €473.50 Million ≈ $553.57 Million |
€2.83 Billion ≈ $3.31 Billion |
+15.59pp |
| 2021-12-31 | 1.12% | €28.00 Million ≈ $32.73 Million |
€2.51 Billion ≈ $2.93 Billion |
-- |
About CLOUDR GROUP LTD.
ClouDr Group Limited provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company's integrated in-hospital solution offers an AI-driven extensive hospital SaaS to assist doctors in diagnosis and treatment, and… Read more